These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36327964)

  • 1. Association of a History of Sleep Disorder With Risk of Mild Cognitive Impairment and Alzheimer's Disease Dementia.
    Choe YM; Suh GH; Kim JW;
    Psychiatry Investig; 2022 Oct; 19(10):840-846. PubMed ID: 36327964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Importance of Diagnosing and the Clinical Potential of Treating Obstructive Sleep Apnea to Delay Mild Cognitive Impairment and Alzheimer's Disease: A Special Focus on Cognitive Performance.
    Fernandes M; Placidi F; Mercuri NB; Liguori C
    J Alzheimers Dis Rep; 2021; 5(1):515-533. PubMed ID: 34368635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of obstructive sleep apnea with cognitive decline and age among non-demented older adults.
    Pan T; Liu S; Ke S; Wang E; Jiang Y; Wang S;
    Neurosci Lett; 2021 Jun; 756():135955. PubMed ID: 33979700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement protein levels in serum astrocyte-derived exosomes are associated with cognitive impairment in obstructive sleep apnea.
    Li M; Sun C; Xue S; Leng B; Sun H; Shen T; Liu X; Li Z; Shang X; Zhang J
    J Clin Sleep Med; 2023 Apr; 19(4):727-739. PubMed ID: 36692174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstructive sleep apnea and longitudinal Alzheimer's disease biomarker changes.
    Bubu OM; Pirraglia E; Andrade AG; Sharma RA; Gimenez-Badia S; Umasabor-Bubu OQ; Hogan MM; Shim AM; Mukhtar F; Sharma N; Mbah AK; Seixas AA; Kam K; Zizi F; Borenstein AR; Mortimer JA; Kip KE; Morgan D; Rosenzweig I; Ayappa I; Rapoport DM; Jean-Louis G; Varga AW; Osorio RS;
    Sleep; 2019 Jun; 42(6):. PubMed ID: 30794315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.
    Sato K; Mano T; Ihara R; Suzuki K; Tomita N; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; Iwatsubo T; Toda T; Iwata A;
    J Alzheimers Dis; 2019; 68(2):777-788. PubMed ID: 30814351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of depression in the insomnia of people with subjective memory impairment, mild cognitive impairment, and dementia in a community sample of elderly individuals in South Korea.
    Kim WH; Kim JH; Kim BS; Chang SM; Lee DW; Cho MJ; Bae JN
    Int Psychogeriatr; 2017 Apr; 29(4):653-661. PubMed ID: 27921991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease trajectories in elders with suspected non-Alzheimer's pathophysiology and its comparison with Alzheimer's disease pathophysiology: a longitudinal study.
    Li JQ; Song JH; Suckling J; Wang YJ; Zuo CT; Zhang C; Gao J; Song YQ; Xie AM; Tan L; Yu JT
    Res Sq; 2023 Mar; ():. PubMed ID: 37034751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of mild behavioural impairment and its association with cognitive and functional impairment in normal cognition, mild cognitive impairment, and mild Alzheimer's dementia.
    Park JI;
    Psychogeriatrics; 2024 May; 24(3):555-564. PubMed ID: 38403289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AD Resemblance Atrophy Index of Brain Magnetic Resonance Imaging in Predicting the Progression of Mild Cognitive Impairment Carrying Apolipoprotein E-ε4 Allele.
    Mai Y; Cao Z; Xu J; Yu Q; Yang S; Tang J; Zhao L; Fang W; Luo Y; Lei M; Mok VCT; Shi L; Liao W; Liu J;
    Front Aging Neurosci; 2022; 14():859492. PubMed ID: 35572149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
    Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
    J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of circulating saturated long-chain fatty acids with risk of mild cognitive impairment and Alzheimer's disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.
    Fan L; Borenstein AR; Wang S; Nho K; Zhu X; Wen W; Huang X; Mortimer JA; Shrubsole MJ; Dai Q;
    EBioMedicine; 2023 Nov; 97():104818. PubMed ID: 37793213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPAP Adherence May Slow 1-Year Cognitive Decline in Older Adults with Mild Cognitive Impairment and Apnea.
    Richards KC; Gooneratne N; Dicicco B; Hanlon A; Moelter S; Onen F; Wang Y; Sawyer A; Weaver T; Lozano A; Carter P; Johnson J
    J Am Geriatr Soc; 2019 Mar; 67(3):558-564. PubMed ID: 30724333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Smailagic N; Vacante M; Hyde C; Martin S; Ukoumunne O; Sachpekidis C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010632. PubMed ID: 25629415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease.
    Suzuki K; Hirakawa A; Ihara R; Iwata A; Ishii K; Ikeuchi T; Sun CK; Donohue M; Iwatsubo T;
    Alzheimers Dement (N Y); 2020; 6(1):e12007. PubMed ID: 32211510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.
    Reijs BLR; Vos SJB; Soininen H; Lötjonen J; Koikkalainen J; Pikkarainen M; Hall A; Vanninen R; Liu Y; Herukka SK; Freund-Levi Y; Frisoni GB; Frölich L; Nobili F; Rikkert MO; Spiru L; Tsolaki M; Wallin ÅK; Scheltens P; Verhey F; Visser PJ
    J Alzheimers Dis; 2017; 60(4):1387-1395. PubMed ID: 29036813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive variability-A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative.
    Anderson ED; Wahoske M; Huber M; Norton D; Li Z; Koscik RL; Umucu E; Johnson SC; Jones J; Asthana S; Gleason CE;
    Alzheimers Dement (Amst); 2016; 4():47-55. PubMed ID: 27489880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).
    Arevalo-Rodriguez I; Smailagic N; Roqué I Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010783. PubMed ID: 25740785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction Models for Conversion From Mild Cognitive Impairment to Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Chen Y; Qian X; Zhang Y; Su W; Huang Y; Wang X; Chen X; Zhao E; Han L; Ma Y
    Front Aging Neurosci; 2022; 14():840386. PubMed ID: 35493941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.